Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:SHR
일자시간출처헤드라인심볼기업
2007/01/1917:20PR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/12/0522:25PR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/11/2817:45PR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingNYSE:SHR
2006/11/2716:33PR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006NYSE:SHR
2006/11/2502:25PR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/11/2318:40PR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisNYSE:SHR
2006/11/0815:54PR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/10/3122:00PR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaNYSE:SHR
2006/10/3104:10PR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/10/2323:39PR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisNYSE:SHR
2006/10/1722:47PR Newswire (US)Family Planning Programs in the Fight Against PovertyNYSE:SHR
2006/10/0521:30PR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)NYSE:SHR
2006/09/1916:58PR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyNYSE:SHR
2006/09/1823:01PR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombNYSE:SHR
2006/09/1517:32PR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugNYSE:SHR
2006/09/1423:00PR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityNYSE:SHR
2006/09/1421:48PR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaNYSE:SHR
2006/09/1319:32PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/09/0420:19PR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandNYSE:SHR
2006/09/0123:00PR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/08/3019:13PR Newswire (US)Group Environmental Report for 2006 PublishedNYSE:SHR
2006/08/1700:50PR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/08/0417:15PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andNYSE:SHR
2006/08/0223:00PR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningNYSE:SHR
2006/07/3123:49PR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLNYSE:SHR
2006/07/3123:36PR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsNYSE:SHR
2006/07/3123:21PR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlNYSE:SHR
2006/07/3123:20PR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/07/2703:46PR Newswire (US)KPMG Values Schering AG Share at EUR 87.63NYSE:SHR
2006/07/2516:28PR Newswire (US)Schering AG Raises Outlook After Strong First Half YearNYSE:SHR
 검색 관련기사 보기:NYSE:SHR